Table 3:
Factors associated with risk of Re-LT
Univariate | Multivariable | |||||
---|---|---|---|---|---|---|
Variable | HR | 95% CI | P-value | HR | 95% CI | P-value |
Recipient age (LDLT) | 0.98 | 0.96–0.99 | 0.003 | 0.97 | 0.95–0.98 | <0.001 |
Bilirubin (LDLT) | 1.03 | 1.01–1.05 | 0.01 | -- | ||
Female sex | 0.70 | 0.47–1.03 | 0.07 | --- | ||
HCV | 1.41 | 0.97–2.05 | 0.08 | 1.83 | 1.21–2.76 | 0.004 |
HCC | 0.73 | 0.40–1.32 | 0.29 | --- | ||
Donor age | 1.03 | 1.01–1.05 | <0.001 | --- | ||
Ethnicity | 0.88 | 0.50–1.55 | 0.66 | --- | ||
Left lobe | 1.10 | 0.51–2.38 | 0.80 | --- | ||
LOS (at LDLT) | 1.02 | 1.01–1.02 | <0.001 | 1.02 | 1.01–1.02 | <0.001 |
Bile leak | 2.16 | 1.43–3.25 | <0.001 | -- | ||
HAT | 24.98 | 16.71–37.36 | <0.001 | 26.3 | 17.3–40.0 | <0.001 |
GI Infection* | 2.70 | 1.30–5.62 | 0.008 | 3.55 | 1.67–7.57 | 0.001 |
Disease recurrence | 5.47 | 2.48–12.06 | <0.001 | 4.07 | 1.80–9.21 | <0.001 |
GI infection included c. difficile colitis or a GI tract infection of bacterial, fungal, or viral origin.